Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer

Figure 8 Survival curves for two competing events, stratified by American Joint Committee on Cancer staging[21], in colorectal cancer patients. Solid and dashed lines represent disease-specific death and non-cancer related death, respectively. A: The effect of the stage on patient survival was marginal in the case of personalized platelet count relative to “at-diagnosis” (pPLT_D, Stage I vs Stage II: P = 0.0847); B: A significant difference was found in personalized platelet count relative to “after-surgery” (pPLT_S, Stage I vs Stage II: P = 0.0314; Stage I vs Stage III: P = 0.0594; Stage I vs Stage IV: P = 0.0335). pPLT_D: Personalized platelet count relative to “at-diagnosis”; pPLT_S: Personalized platelet count relative to “after-surgery”.